Suicide Gene Therapy to Increase the Safety of Chimeric Antigen Receptor-Redirected T Lymphocytes
<p>Chimeric antigen receptors (CARs) are generated by fusing the antigen-binding motif of a monoclonal antibody (mAb) with the signal transduction machinery of the T-cell receptor (TCR). The genetic modification of T lymphocytes with chimeric receptors specific for tumor-associated antigens (T...
Main Author: | Monica Casucci, Attilio Bondanza |
---|---|
Format: | Article |
Language: | English |
Published: |
Ivyspring International Publisher
2011-01-01
|
Series: | Journal of Cancer |
Online Access: | http://www.jcancer.org/v02p0378.htm |
Similar Items
-
Increasing the safety and efficacy of chimeric antigen receptor T cell therapy
by: Hua Li, et al.
Published: (2017-04-01) -
Antigen-specific T cell activation independently of the MHC: chimeric antigen receptor (CAR)-redirected T cells.
by: Hinrich eAbken, et al.
Published: (2013-11-01) -
Correction: In Vitro Pre-Clinical Validation of Suicide Gene Modified Anti-CD33 Redirected Chimeric Antigen Receptor T-Cells for Acute Myeloid Leukemia.
by: Kentaro Minagawa, et al.
Published: (2017-01-01) -
In situ antigen modification-based target-redirected universal chimeric antigen receptor T (TRUE CAR-T) cell therapy in solid tumors
by: Zhichen Sun, et al.
Published: (2022-03-01) -
Chimeric antigen receptor-modified T cell therapy in chronic lymphocytic leukemia
by: Yixin Zou, et al.
Published: (2018-11-01)